Chronic Kidney Disease

The AJMC® Chronic Kidney Disease compendium is a comprehensive resource for clinical news and expert insights on the condition and treatment of loss of kidney function.

Latest News

FDA Approved. | Image Credit: Nirusmee - stock.adobe.com .jpeg
Oxylanthanum Carbonate Fails to Secure FDA Approval for Hyperphosphatemia, CKD

June 30th 2025

FDA issues a complete response letter for oxylanthanum carbonate, a treatment for hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis.

Woman laying on bed with mobile phone, using medical app | Prostock-studio - stock.adobe.com
Smartphone-Powered CKD Screening Yields 2.5-Fold Increase in Testing, Early Diagnoses

June 27th 2025

Clinical trial researchers interact with data | Image Credit: elenabsl - stock.adobe.com .jpeg
Lorundrostat Yields Promising Results for Treatment of Hypertension in Patients with CKD and Albuminuria

June 20th 2025

Medicine doctor analysis and diagnosis checking health of patient online and testing result with modern virtual interface on laptop with stethoscope in hand, Online Medical global network - ipopba - stock.adobe.com.jpeg
Dual-Biomarker Approach Best for Equitable Kidney Disease Risk Assessment, New Data Find

June 11th 2025

Dialysis nurse | image credit istockphoto.com
Dialysis Outcomes Tied to Nephrologist Facility Quality, Widening Racial Inequities

May 30th 2025

Population Health Management of Chronic Kidney Disease (CKD)

An expert panel discusses chronic kidney disease (CKD), its impact on cardiovascular disease, and the methods of treatment used on the patient populations.

Panel members

More News

Shifting Dialysis Away From Employer-Based Coverage Cost Medicare $3 Billion, Study Finds
March 18th 2021

Shifting Dialysis Away From Employer-Based Coverage Cost Medicare $3 Billion, Study Finds

Allison Inserro
The study examined the cost to Medicare when patients with end-stage renal disease switched from their employer-based health insurance to Medicare between 2007 and 2017 before the end of the 30-month coordination period.
Study Recommends Rate of Physical Activity for Patients With CKD
March 12th 2021

Study Recommends Rate of Physical Activity for Patients With CKD

Larry Hanover
The study, published on World Kidney Day, is the first to report the optimal amount of activity in patients with chronic kidney disease, according to the authors.
Study Illustrates Kidney Impact After COVID-19 Resolves
March 10th 2021

Study Illustrates Kidney Impact After COVID-19 Resolves

Allison Inserro
More than a year into the COVID-19 pandemic, a new study suggests that individuals recovering from acute kidney injury stemming from COVID-19 will require kidney monitoring after they leave the hospital.
Study Describes AKI Incidence in Children With COVID-19, MIS-C
March 6th 2021

Study Describes AKI Incidence in Children With COVID-19, MIS-C

Allison Inserro
A retrospective study looking at pediatric patients hospitalized in 4 New York hospitals in 2020 with COVID-19 or multisystem inflammatory syndrome in children (MIS-C) found that acute kidney injury (AKI) occurred in 11.8% of patients.
kidney picture
March 5th 2021

Kidney Transplants Benefit Patients With SCD, But Few Have Chance to Receive Them

Allison Inserro
Despite benefitting from organ transplants similarly to other patients with kidney failure, a new study found patients with kidney failure associated with sickle cell disease (SCD) are less likely to receive transplants.
Genetic Picture Emerges of Polycystic Kidney Disease in Ireland
February 27th 2021

Genetic Picture Emerges of Polycystic Kidney Disease in Ireland

Larry Hanover
Cutting-edge genetic tools diagnosed 83% of Irish patients with polycystic kidney disease (PKD), identified 36 novel variants, and discovered that seemingly unrelated individuals with the same variant likely inherited it from a common ancestor.
Caring for kidneys
February 25th 2021

Slowing CKD, Adherence to Care Guidelines Need to Improve, Study Says

Larry Hanover
Adherence to guidelines for slowing chronic kidney disease is low, with substantial variation among the United States and other countries.
Review Suggests Mortality Risk Factors for Patients on Dialysis
February 20th 2021

Review Suggests Mortality Risk Factors for Patients on Dialysis

Larry Hanover
Older patients are at greater risk of death in the earliest stages of dialysis, while females possibly are at a higher risk than men, a review of studies found.
Even Patients With Mild CKD Have Higher Hospitalization Rates, Study Says
February 20th 2021

Even Patients With Mild CKD Have Higher Hospitalization Rates, Study Says

Larry Hanover
Patients with chronic kidney disease (CKD) healthy enough not to have seen a specialist have higher hospitalization rates than the general population, according to a recent study.
Palliative Care in ESRD Is Possible With Right Planning, Education, Tools
February 12th 2021

Palliative Care in ESRD Is Possible With Right Planning, Education, Tools

Allison Inserro
Planning and education can help create systemwide change in order to implement greater use of advance care planning and palliative care for those with end-stage renal disease (ESRD).
Brandi Riddle
February 6th 2021

Brandi Riddle Discusses Technology’s Role in the Future of Kidney Care

Brandi Riddle, chief financial officer at Strive Health, discussed the role technology and predictive analytics will play in changing kidney care in the future.
A Look at Recent Novel Iron Replacement Therapies for the Treatment of Anemia in CKD
February 6th 2021

A Look at Recent Novel Iron Replacement Therapies for the Treatment of Anemia in CKD

Jaime Rosenberg
Noting each of their benefits, the researchers also caution that to better characterize their safety and efficacy, there’s a need for further investigation among larger patient pools.
Study Highlights Suboptimal Prescribing of Anemia Medication in Patients With NDD-CKD
February 4th 2021

Study Highlights Suboptimal Prescribing of Anemia Medication in Patients With NDD-CKD

Jaime Rosenberg
Data from nearly 3000 patients across multiple countries with the disease showed that undertreatment was most notable among patient with hemoglobin (Hb) <10 g/dL.
Caring for Individuals With Kidney Disease During the Pandemic
January 20th 2021

Caring for Individuals With Kidney Disease During the Pandemic

Mary Dittrich, MD
Nephrologist Mary Dittrich, MD, the chief medical officer and executive vice president of U.S. Renal Care as well as cofounder and partner of Boise Kidney & Hypertension Institute, discusses how to keep patients safe while providing high-quality kidney care during the coronavirus disease 2019 pandemic.
Graphic depicting lineage
January 16th 2021

Family History, Genetics May Help to Predict, Detect Early-Stage CKD

Skylar Jeremias
A population-based study from the Netherlands showed that individuals with had at least 1 direct relative affected with chronic kidney disease (CKD), suggesting that biomarkers for CKD can aid in detecting the early stages of the disease.
Kidney graphic
January 8th 2021

FDA Grants Priority Review to Dapagliflozin for CKD

Skylar Jeremias
The FDA decision on dapaglifozin for CKD is expected in the second quarter of 2021.
Large Swedish Study Says Stopping RAS Inhibitors Leads to Worse CKD Outcomes
January 3rd 2021

Large Swedish Study Says Stopping RAS Inhibitors Leads to Worse CKD Outcomes

AJMC Staff
A new study from Sweden cautions against routine discontinuation of renin-angiotensin system (RAS) inhibitors in patients with chronic kidney disease (CKD).
Dr Guofen Yan Considers Strategies for Improving CKD Outcomes in Minority Populations
December 31st 2020

Dr Guofen Yan Considers Strategies for Improving CKD Outcomes in Minority Populations

Slowing progression of chronic kidney disease can help mitigate adverse outcomes in minority populations, said Guofen Yan, PhD, associate professor of biostatistics in the Department of Public Health Sciences at the University of Virginia School of Medicine.
Dr Kunihiro Matsushita Lays Out the Benefits of the CKD Patch Approach
December 31st 2020

Dr Kunihiro Matsushita Lays Out the Benefits of the CKD Patch Approach

This approach allows clinicians to keep using existing prediction models and incorporate chronic kidney disease (CKD) data seamlessly to calibrate patients' risks, said Kunihiro Matsushita, MD, an associate professor in the Department of Epidemiology and Division of Cardiology at Johns Hopkins University.
Top 5 Most-Read Chronic Kidney Disease Articles of 2020
December 28th 2020

Top 5 Most-Read Chronic Kidney Disease Articles of 2020

Allison Inserro
Two story lines predominated renal news in 2020: coronavirus disease 2019's effect on the kidneys and the overwhelming benefits of sodium-glucose cotransporter 2 inhibitors for those with chronic kidney disease and type 2 diabetes.
Contributor: How Payers Can Be Effective in New Value-Based Models for CKD
December 26th 2020

Contributor: How Payers Can Be Effective in New Value-Based Models for CKD

Precision Value & Health Ryan Cox
The author discusses how value-based payment models in chronic kidney disease can improve total cost and quality of care for patienst with chronic kidney disease (CKD).
Virtual Platform Allows Transplant Evaluations, Wait-Listing to Continue Despite Pandemic
December 26th 2020

Virtual Platform Allows Transplant Evaluations, Wait-Listing to Continue Despite Pandemic

Skylar Jeremias
A study evaluating whether a virtual platform can improve access to evaluations for kidney transplants found that surgical teams could continue to keep up with evaluations adding patients to wait lists during the pandemic.
Researchers Discuss Closing Racial Gaps in ESKD Incidence Rates
December 19th 2020

Researchers Discuss Closing Racial Gaps in ESKD Incidence Rates

Bringing together genetic work with social determinants of health can improve understanding of factors associated with ESKD disparities, said Adriana Hung, MD, MPH, associate professor of medicine at Vanderbilt University, and Bryce Rowan, a statistical genetic analyst.
Study Describes Early Benefit, Effectiveness of RASi for CKD
December 18th 2020

Study Describes Early Benefit, Effectiveness of RASi for CKD

Larry Hanover
An observational study showed that it may be more effective to start patients on a renin-angiotensin system inhibitor (RASi) than a calcium channel blocker in delaying progression of advanced kidney disease.
Study Shows Effect of COVID-19 on Hospitalization Risk in CKD
December 12th 2020

Study Shows Effect of COVID-19 on Hospitalization Risk in CKD

AJMC Staff
Patients with COVID-19 and end-stage renal disease were 11 times more likely to be admitted to the hospital than patients without kidney disease.
Dr George Bakris
December 12th 2020

Dr George Bakris on Discontinuation Rates, CV Outcomes of FIDELIO-DKD

A variety of factors contributed to discontinuation rates in FIDELIO-DKD, said George Bakris, MD, professor of medicine and director of the American Heart Association Comprehensive Hypertension Center at the University of Chicago Medicine.
Study Examines Clinical Implications of Removing Race From eGFR in CKD
December 4th 2020

Study Examines Clinical Implications of Removing Race From eGFR in CKD

Allison Inserro
As higher estimated glomerular filtration rate (eGFR) equations indicate better kidney function, there has been increasing recognition that this may lead to inequitable and delayed care in treating chronic kidney disease (CKD) in Black adults.
Dr Jill Krissberg on Addressing Racial Disparities in Glomerular Disease
December 3rd 2020

Dr Jill Krissberg on Addressing Racial Disparities in Glomerular Disease

Making sure patients have a strong medical home and close follow-up is one way to reduce glomerular disease disparities among children, said Jill Krissberg, MD, a pediatric nephrology fellow at Stanford University School of Medicine.
Contributor: The Wrong Way to Design a Medicare Mandatory Demonstration
November 27th 2020

Contributor: The Wrong Way to Design a Medicare Mandatory Demonstration

Jackson Williams, JD
Jackson Williams is vice president, public policy at Dialysis Patient Citizens. Previously he worked at the Centers for Medicare and Medicaid Services (CMS); was a health services researcher in the AARP Public Policy Institute; and a lobbyist on health policy issues for 3 nonprofit associations. His more than 2 decades of experience monitoring, studying, and overseeing federal demonstration projects include time as a project officer at CMMI and serving as the consumer representative on a Medicare pilot site’s governing body.
Dr George Bakris Discusses Next Steps for Finerenone
November 27th 2020

Dr George Bakris Discusses Next Steps for Finerenone

If results from FIGARO-DKD are as positive as those of FIDELIO-DKD, the field will work aggressively to get the message out, said George Bakris, MD, professor of medicine and director of the American Heart Association Comprehensive Hypertension Center at the University of Chicago Medicine.
<1
...
45678910111213>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo